Home » Topics » BioWorld Science

BioWorld Science
RSS

Searle continues to investigate COX-2 inhibitors for inflammation

Oct. 11, 1996

Novel strategy for AIDS reported by UCSF researchers

Oct. 11, 1996

HIV inhibited by chemokine antagonist

Oct. 11, 1996

IND filed for MiKasome

Oct. 11, 1996

Ingenol derivatives as anti-HIV agents

Oct. 11, 1996

Merck & Co. cleared to market protease inhibitor in EU

Oct. 11, 1996

Anti-HIV agents from Nippon Paper

Oct. 11, 1996

EU approval for Roche AIDS drug

Oct. 11, 1996

Anti-HIV agents from Department of Health & Human Services

Oct. 11, 1996

Genes associated with latent CMV infection discovered

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...